Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 3
1954 1
1955 1
1956 2
1957 2
1958 1
1959 2
1960 1
1961 1
1962 5
1963 4
1964 1
1965 3
1966 4
1967 7
1968 4
1969 6
1970 5
1971 5
1972 5
1973 10
1974 6
1975 7
1976 8
1977 10
1978 10
1979 5
1980 7
1981 8
1982 12
1983 11
1984 7
1985 10
1986 13
1987 19
1988 22
1989 30
1990 29
1991 41
1992 33
1993 43
1994 47
1995 42
1996 39
1997 43
1998 45
1999 63
2000 70
2001 80
2002 82
2003 86
2004 106
2005 133
2006 122
2007 136
2008 148
2009 153
2010 185
2011 225
2012 242
2013 236
2014 290
2015 279
2016 302
2017 286
2018 283
2019 273
2020 349
2021 363
2022 341
2023 302
2024 333
2025 317

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,750 results

Results by year

Filters applied: . Clear all
Page 1
Muscle regeneration is improved by hot water immersion but unchanged by cold following a simulated musculoskeletal injury in humans.
Dablainville V, Mornas A, Normand-Gravier T, Al-Mulla M, Papakostas E, Olory B, Fermin TM, Zampeli F, Nader N, Alhammoud M, Bayne F, Sanchez AMJ, Cardinale M, Candau R, Bernardi H, Racinais S. Dablainville V, et al. Among authors: sanchez amj. J Physiol. 2025 May 28. doi: 10.1113/JP287777. Online ahead of print. J Physiol. 2025. PMID: 40437768
Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial.
Kim P, Sanchez AM, Penke TJR, Tuson HH, Kime JC, McKee RW, Slone WL, Conley NR, McMillan LJ, Prybol CJ, Garofolo PM. Kim P, et al. Among authors: sanchez am. Lancet Infect Dis. 2024 Dec;24(12):1319-1332. doi: 10.1016/S1473-3099(24)00424-9. Epub 2024 Aug 9. Lancet Infect Dis. 2024. PMID: 39134085 Clinical Trial.
GA2LEN ANACARE consensus statement: Potential of omalizumab in food allergy management.
Zuberbier T, Muraro A, Nurmatov U, Arasi S, Stevanovic K, Anagnostou A, Bonaguro R, Chinthrajah S, Lack G, Fiocchi A, Le TM, Turner P, Lozano MA, Angier E, Barni S, Bégin P, Ballmer-Weber B, Cardona V, Bindslev-Jensen C, Cianferoni A, de Jong N, de Silva D, Deschildre A, Galvin AD, Ebisawa M, Fleischer DM, Gerdts J, Giovannini M, Gradman J, Halken S, Arshad SH, Khaleva E, Lau S, Loh R, Mäkelä MJ, Marchisotto MJ, Morandini L, Mortz CG, Nilsson C, Nowak-Wegrzyn A, Podestà M, Poulsen LK, Roberts G, Rodríguez Del Río P, Sampson HA, Sánchez A, Schnadt S, Smith PK, Szajewska H, Mitrevska NT, Toniolo A, Venter C, Warner A, Wong GWK, Wood R, Worm M. Zuberbier T, et al. Among authors: sanchez a. Clin Transl Allergy. 2024 Nov;14(11):e70002. doi: 10.1002/clt2.70002. Clin Transl Allergy. 2024. PMID: 39506193 Free PMC article. Review.
Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA).
Clark VC, Strange C, Strnad P, Sanchez AJ, Kwo P, Pereira VM, van Hoek B, Barjaktarevic I, Corsico AG, Pons M, Goldklang M, Gray M, Kuhn B, Vargas HE, Vierling JM, Vuppalanchi R, Brantly M, Kappe N, Chang T, Schluep T, Zhou R, Hamilton J, San Martin J, Loomba R. Clark VC, et al. Among authors: sanchez aj. Gastroenterology. 2024 Oct;167(5):1008-1018.e5. doi: 10.1053/j.gastro.2024.06.028. Epub 2024 Jul 2. Gastroenterology. 2024. PMID: 38964420 Free article. Clinical Trial.
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.
ACTIV-3/TICO Study Group; Barkauskas C, Mylonakis E, Poulakou G, Young BE, Vock DM, Siegel L, Engen N, Grandits G, Mosaly NR, Vekstein AM, Rogers R, Shehadeh F, Kaczynski M, Mylona EK, Syrigos KN, Rapti V, Lye DC, Hui DS, Leither L, Knowlton KU, Jain MK, Marines-Price R, Osuji A, Overcash JS, Kalomenidis I, Barmparessou Z, Waters M, Zepeda K, Chen P, Torbati S, Kiweewa F, Sebudde N, Almasri E, Hughes A, Bhagani SR, Rodger A, Sandkovsky U, Gottlieb RL, Nnakelu E, Trautner B, Menon V, Lutaakome J, Matthay M, Robinson P, Protopapas K, Koulouris N, Kimuli I, Baduashvili A, Braun DL, Günthard HF, Ramachandruni S, Kidega R, Kim K, Hatlen TJ, Phillips AN, Murray DD, Jensen TO, Padilla ML, Accardi EX, Shaw-Saliba K, Dewar RL, Teitelbaum M, Natarajan V, Laverdure S, Highbarger HC, Rehman MT, Vogel S, Vallée D, Crew P, Atri N, Schechner AJ, Pett S, Hudson F, Badrock J, Touloumi G, Brown SM, Self WH, North CM, Ginde AA, Chang CC, Kelleher A, Nagy-Agren S, Vasudeva S, Looney D, Nguyen HH, Sánchez A, Weintrob AC, Grund B, Sharma S, Reilly CS, Paredes R, Bednarska A, Gerry NP, Babiker AG, Davey VJ, Gelijns AC, Higgs ES, Kan V, Matthews G, Thompson BT, Legenne P, Chandra R, Lane HC, Neato… See abstract for full author list ➔ ACTIV-3/TICO Study Group, et al. Among authors: sanchez a. Ann Intern Med. 2022 Sep;175(9):1266-1274. doi: 10.7326/M22-1503. Epub 2022 Aug 9. Ann Intern Med. 2022. PMID: 35939810 Free PMC article. Clinical Trial.
A Protocol for the Isolation of Oval Cells without Preconditioning.
Olivera-Salazar R, Sánchez A, Herrera B, García-Sáez J, Vega-Clemente L, Villarejo Campos P, García-Olmo D, García-Arranz M. Olivera-Salazar R, et al. Among authors: sanchez a. Int J Mol Sci. 2024 Sep 29;25(19):10497. doi: 10.3390/ijms251910497. Int J Mol Sci. 2024. PMID: 39408831 Free PMC article.
Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial.
España-Cueto S, Loste C, Lladós G, López C, Santos JR, Dulsat G, García A, Carmezim J, Carabia J, Ancochea Á, Fernández-Prendres C, Morales-Indiano C, Quirant B, Martínez-Cáceres E, Sanchez A, Parraga IG, Chamorro A, San José A, Abad E, Muñoz-Moreno JA, Prats A, Fumaz CR, Coll-Fernández R, Estany C, Torrano P, Puig J, Clotet B, Tebé C, Massanella M, Paredes R, Mateu L. España-Cueto S, et al. Among authors: sanchez a. Nat Commun. 2025 Feb 24;16(1):1929. doi: 10.1038/s41467-025-57198-7. Nat Commun. 2025. PMID: 39994269 Free PMC article. Clinical Trial.
5,750 results